Laparoscopic Adjustable Gastric Banding-Should a Second Chance Be Given?

Area of Science:

• Bariatric Surgery
• Obesity Medicine
• Metabolic Surgery

Background:

• Obesity is a global pandemic associated with numerous comorbidities.
• Laparoscopic adjustable gastric banding (LAGB) is a safe surgical option for obesity treatment.
• LAGB can lead to significant weight loss and improved health outcomes.

Purpose of the Study:

• To assess the impact of weight loss after LAGB on obesity-related comorbidities.
• To identify predictors of successful surgical outcomes.
• To determine patient subgroups that benefit most from LAGB.

Main Methods:

• A study of 99 severely obese patients undergoing LAGB.
• Pre-operative and 1, 2, and 5-year post-operative data were analyzed.
• Statistical analysis was performed using SPSS software.

Main Results:

• Significant reductions in BMI, A1c, and triglycerides were observed post-LAGB.
• Greatest improvements in these metrics were noted 2 years after surgery.
• Younger age, shorter diabetes duration, and lower pre-operative systolic blood pressure predicted better outcomes.

Conclusions:

• Younger patients with less severe obesity and comorbidities are ideal candidates for LAGB.
• Predictors of successful weight loss include younger age and lower comorbidity severity.
• LAGB remains a viable option for select obese patients.